Abstract
The zebrafish larvae have emerged as a powerful model for studying tumorigenesis in vivo, with remarkable conservation with mammals in genetics, molecular and cell biology. Zebrafish tumor models bear the significant advantages of optical clarity in comparison to that in the mammalian models, allowing noninvasive investigation of the tumor cell and its microenvironment at single-cell resolution. Here we review recent progressions in the field of zebrafish models of solid tumor diseases in two main categories: the genetically engineered tumor models in which all cells in the tumor microenvironment are zebrafish cells, and xenograft tumor models in which the tumor microenvironment is composed of zebrafish cells and cells from other species. Notably, the zebrafish patient-derived xenograft (zPDX) models can be used for personalized drug assessment on primary tumor biopsies, including the pancreatic cancer. For the future studies, a series of high throughput drug screenings on the library of transgenic zebrafish models of solid tumor are expected to provide systematic database of oncogenic mutation, cell-of-origin, and leading compounds; and the humanization of zebrafish in genetics and cellular composition will make it more practical hosts for zPDX modeling. Together, zebrafish tumor model systems are unique and convenient in vivo platforms, with great potential to serve as valuable tools for cancer researches.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Allen-Rhoades W, Whittle SB, Rainusso N (2018) Pediatric solid tumors of infancy: an overview. Pediatr Rev 39(2):57–67. https://doi.org/10.1542/pir.2017-0057
Avci ME, Keskus AG, Targen S, Isilak ME, Ozturk M, Atalay RC, Adams MM, Konu O (2018) Development of a novel zebrafish xenograft model in ache mutants using liver cancer cell lines. Sci Rep 8(1):1570. https://doi.org/10.1038/s41598-018-19817-w
Balar AV, Weber JS (2017) PD-1 and PD-L1 antibodies in cancer: current status and future directions. Cancer Immunol Immunother 66(5):551–564. https://doi.org/10.1007/s00262-017-1954-6
Ban J, Aryee DN, Fourtouna A, van der Ent W, Kauer M, Niedan S, Machado I, Rodriguez-Galindo C, Tirado OM, Schwentner R, Picci P, Flanagan AM, Berg V, Strauss SJ, Scotlandi K, Lawlor ER, Snaar-Jagalska E, Llombart-Bosch A, Kovar H (2014) Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma. Cancer Res 74(22):6578–6588. https://doi.org/10.1158/0008-5472.CAN-14-1736
Barriuso J, Nagaraju R, Hurlstone A (2015) Zebrafish: a new companion for translational research in oncology. Clin Cancer Res 21(5):969–975. https://doi.org/10.1158/1078-0432.CCR-14-2921
Belikov AV (2017) The number of key carcinogenic events can be predicted from cancer incidence. Sci Rep 7(1):12170. https://doi.org/10.1038/s41598-017-12448-7
Berghmans S, Murphey RD, Wienholds E, Neuberg D, Kutok JL, Fletcher CD, Morris JP, Liu TX, Schulte-Merker S, Kanki JP, Plasterk R, Zon LI, Look AT (2005) tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc Natl Acad Sci U S A 102(2):407–412. https://doi.org/10.1073/pnas.0406252102
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492
Cekanova M, Rathore K (2014) Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Des Devel Ther 8:1911–1921. https://doi.org/10.2147/DDDT.S49584
Chiavacci E, Rizzo M, Pitto L, Patella F, Evangelista M, Mariani L, Rainaldi G (2015) The zebrafish/tumor xenograft angiogenesis assay as a tool for screening anti-angiogenic miRNAs. Cytotechnology 67(6):969–975. https://doi.org/10.1007/s10616-014-9735-y
DE Fatima FBDC, DE Castro SAC, Muniz J, RC DA, Lamarao LM, DE Fatima AMNC, DE Assumpcao PP, Burbano RR (2018) Deregulation of the SRC family tyrosine kinases in gastric carcinogenesis in non-human primates. Anticancer Res 38(11):6317–6320. https://doi.org/10.21873/anticanres.12988
den Hertog J (2016) Tumor suppressors in zebrafish: from TP53 to PTEN and beyond. Adv Exp Med Biol 916:87–101. https://doi.org/10.1007/978-3-319-30654-4_4
Drabsch Y, He S, Zhang L, Snaar-Jagalska BE, Ten DP (2013) Transforming growth factor-beta signalling controls human breast cancer metastasis in a zebrafish xenograft model. Breast Cancer Res 15(6):R106. https://doi.org/10.1186/bcr3573
Evason KJ, Francisco MT, Juric V, Balakrishnan S, Lopez PMP, Gordan JD, Kakar S, Spitsbergen J, Goga A, Stainier DY (2015) Identification of chemical inhibitors of beta-catenin-driven liver tumorigenesis in zebrafish. PLoS Genet 11(7):e1005305. https://doi.org/10.1371/journal.pgen.1005305
Fior R, Povoa V, Mendes RV, Carvalho T, Gomes A, Figueiredo N, Ferreira MG (2017) Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts. Proc Natl Acad Sci U S A 114(39):E8234–E8243. https://doi.org/10.1073/pnas.1618389114
Franzetti GA, Laud-Duval K, van der Ent W, Brisac A, Irondelle M, Aubert S, Dirksen U, Bouvier C, de Pinieux G, Snaar-Jagalska E, Chavrier P, Delattre O (2017) Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells. Oncogene 36(25):3505–3514. https://doi.org/10.1038/onc.2016.498
Gardner HL, Fenger JM, London CA (2016) Dogs as a model for cancer. Annu Rev Anim Biosci 4:199–222. https://doi.org/10.1146/annurev-animal-022114-110911
Gaudenzi G, Albertelli M, Dicitore A, Wurth R, Gatto F, Barbieri F, Cotelli F, Florio T, Ferone D, Persani L, Vitale G (2017) Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors. Endocrine 57(2):214–219. https://doi.org/10.1007/s12020-016-1048-9
Guo M, Wei H, Hu J, Sun S, Long J, Wang X (2015) U0126 inhibits pancreatic cancer progression via the KRAS signaling pathway in a zebrafish xenotransplantation model. Oncol Rep 34(2):699–706. https://doi.org/10.3892/or.2015.4019
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. https://doi.org/10.1016/j.cell.2011.02.013
He S, Mansour MR, Zimmerman MW, Ki DH, Layden HM, Akahane K, Gjini E, de Groh ED, Perez-Atayde AR, Zhu S, Epstein JA, Look AT (2016) Synergy between loss of NF1 and overexpression of MYCN in neuroblastoma is mediated by the GAP-related domain. Elife 5:5. https://doi.org/10.7554/eLife.14713
He S, Jing CB, Look AT (2017) Zebrafish models of leukemia. Methods Cell Biol 138:563–592. https://doi.org/10.1016/bs.mcb.2016.11.013
Hou Y, Chu M, Du FF, Lei JY, Chen Y, Zhu RY, Gong XH, Ma X, Jin J (2013) Recombinant disintegrin domain of ADAM15 inhibits the proliferation and migration of Bel-7402 cells. Biochem Biophys Res Commun 435(4):640–645. https://doi.org/10.1016/j.bbrc.2013.05.037
Ikonomopoulou MP, Fernandez-Rojo MA, Pineda SS, Cabezas-Sainz P, Winnen B, Morales R, Brust A, Sanchez L, Alewood PF, Ramm GA, Miles JJ, King GF (2018) Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation. Sci Rep 8(1):11519. https://doi.org/10.1038/s41598-018-29826-4
Jo DH, Son D, Na Y, Jang M, Choi JH, Kim JH, Yu YS, Seok SH, Kim JH (2013) Orthotopic transplantation of retinoblastoma cells into vitreous cavity of zebrafish for screening of anticancer drugs. Mol Cancer 12:71. https://doi.org/10.1186/1476-4598-12-71
Kim IS, Heilmann S, Kansler ER, Zhang Y, Zimmer M, Ratnakumar K, Bowman RL, Simon-Vermot T, Fennell M, Garippa R, Lu L, Lee W, Hollmann T, Xavier JB, White RM (2017) Microenvironment-derived factors driving metastatic plasticity in melanoma. Nat Commun 8:14343. https://doi.org/10.1038/ncomms14343
Kirchberger S, Sturtzel C, Pascoal S, Distel M (2017) Quo natas, Danio?-Recent progress in modeling cancer in zebrafish. Front Oncol 7:186. https://doi.org/10.3389/fonc.2017.00186
Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S (2010) The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas 39(6):707–712. https://doi.org/10.1097/MPA.0b013e3181ec124e
Knudson AG (2001) Two genetic hits (more or less) to cancer. Nat Rev Cancer 1(2):157–162. https://doi.org/10.1038/35101031
Korzh S, Pan X, Garcia-Lecea M, Winata CL, Pan X, Wohland T, Korzh V, Gong Z (2008) Requirement of vasculogenesis and blood circulation in late stages of liver growth in zebrafish. BMC Dev Biol 8:84. https://doi.org/10.1186/1471-213X-8-84
Kwan W, North TE (2017) Netting novel regulators of hematopoiesis and hematologic malignancies in zebrafish. Curr Top Dev Biol 124:125–160. https://doi.org/10.1016/bs.ctdb.2016.11.005
Latifi A, Abubaker K, Castrechini N, Ward AC, Liongue C, Dobill F, Kumar J, Thompson EW, Quinn MA, Findlay JK, Ahmed N (2011) Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile. J Cell Biochem 112(10):2850–2864. https://doi.org/10.1002/jcb.23199
Lee LM, Seftor EA, Bonde G, Cornell RA, Hendrix MJ (2005) The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn 233(4):1560–1570. https://doi.org/10.1002/dvdy.20471
Leung A, Veinotte CJ, Melong N, Oh MH, Chen K, Enfield K, Backstrom I, Warburton C, Yapp D, Berman JN, Bally MB, Lockwood WW (2017) In vivo validation of PAPSS1 (3′-phosphoadenosine 5′-phosphosulfate synthase 1) as a cisplatin-sensitizing therapeutic target. Clin Cancer Res 23(21):6555–6566. https://doi.org/10.1158/1078-0432.CCR-17-0700
Li Z, Huang X, Zhan H, Zeng Z, Li C, Spitsbergen JM, Meierjohann S, Schartl M, Gong Z (2012) Inducible and repressable oncogene-addicted hepatocellular carcinoma in Tet-on xmrk transgenic zebrafish. J Hepatol 56(2):419–425. https://doi.org/10.1016/j.jhep.2011.07.025
Li Z, Zheng W, Wang Z, Zeng Z, Zhan H, Li C, Zhou L, Yan C, Spitsbergen JM, Gong Z (2013) A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors. Dis Model Mech 6(2):414–423. https://doi.org/10.1242/dmm.010462
Liu S, Leach SD (2011) Screening pancreatic oncogenes in zebrafish using the Gal4/UAS system. Methods Cell Biol 105:367–381. https://doi.org/10.1016/B978-0-12-381320-6.00015-1
Lord CJ, Ashworth A (2012) The DNA damage response and cancer therapy. Nature 481(7381):287–294. https://doi.org/10.1038/nature10760
Lu JW, Yang WY, Tsai SM, Lin YM, Chang PH, Chen JR, Wang HD, Wu JL, Jin SL, Yuh CH (2013) Liver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafish. PLoS One 8(10):e76951. https://doi.org/10.1371/journal.pone.0076951
Lu JW, Liao CY, Yang WY, Lin YM, Jin SL, Wang HD, Yuh CH (2014) Overexpression of endothelin 1 triggers hepatocarcinogenesis in zebrafish and promotes cell proliferation and migration through the AKT pathway. PLoS One 9(1):e85318. https://doi.org/10.1371/journal.pone.0085318
MacRae CA, Peterson RT (2015) Zebrafish as tools for drug discovery. Nat Rev Drug Discov 14(10):721–731. https://doi.org/10.1038/nrd4627
Maddalo D, Manchado E, Concepcion CP, Bonetti C, Vidigal JA, Han YC, Ogrodowski P, Crippa A, Rekhtman N, de Stanchina E, Lowe SW, Ventura A (2014) In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature 516(7531):423–427. https://doi.org/10.1038/nature13902
Maresch R, Mueller S, Veltkamp C, Ollinger R, Friedrich M, Heid I, Steiger K, Weber J, Engleitner T, Barenboim M, Klein S, Louzada S, Banerjee R, Strong A, Stauber T, Gross N, Geumann U, Lange S, Ringelhan M, Varela I, Unger K, Yang F, Schmid RM, Vassiliou GS, Braren R, Schneider G, Heikenwalder M, Bradley A, Saur D, Rad R (2016) Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice. Nat Commun 7:10770. https://doi.org/10.1038/ncomms10770
Mercatali L, La Manna F, Groenewoud A, Casadei R, Recine F, Miserocchi G, Pieri F, Liverani C, Bongiovanni A, Spadazzi C, de Vita A, van der Pluijm G, Giorgini A, Biagini R, Amadori D, Ibrahim T, Snaar-Jagalska E (2016) Development of a patient-derived xenograft (PDX) of breast cancer bone metastasis in a zebrafish model. Int J Mol Sci 17(8). https://doi.org/10.3390/ijms17081375
Mir R, Pradhan SJ, Patil P, Mulherkar R, Galande S (2016) Wnt/beta-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression. Oncogene 35(13):1679–1691. https://doi.org/10.1038/onc.2015.232
Moore JC, Tang Q, Yordan NT, Moore FE, Garcia EG, Lobbardi R, Ramakrishnan A, Marvin DL, Anselmo A, Sadreyev RI, Langenau DM (2016) Single-cell imaging of normal and malignant cell engraftment into optically clear prkdc-null SCID zebrafish. J Exp Med 213(12):2575–2589. https://doi.org/10.1084/jem.20160378
Moshal KS, Ferri-Lagneau KF, Haider J, Pardhanani P, Leung T (2011) Discriminating different cancer cells using a zebrafish in vivo assay. Cancers (Basel) 3(4):4102–4113. https://doi.org/10.3390/cancers3044102
Mueller S, Engleitner T, Maresch R, Zukowska M, Lange S, Kaltenbacher T, Konukiewitz B, Ollinger R, Zwiebel M, Strong A, Yen HY, Banerjee R, Louzada S, Fu B, Seidler B, Gotzfried J, Schuck K, Hassan Z, Arbeiter A, Schonhuber N, Klein S, Veltkamp C, Friedrich M, Rad L, Barenboim M, Ziegenhain C, Hess J, Dovey OM, Eser S, Parekh S, Constantino-Casas F, de la Rosa J, Sierra MI, Fraga M, Mayerle J, Kloppel G, Cadinanos J, Liu P, Vassiliou G, Weichert W, Steiger K, Enard W, Schmid RM, Yang F, Unger K, Schneider G, Varela I, Bradley A, Saur D, Rad R (2018) Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes. Nature 554(7690):62–68. https://doi.org/10.1038/nature25459
Nguyen AT, Emelyanov A, Koh CH, Spitsbergen JM, Lam SH, Mathavan S, Parinov S, Gong Z (2011) A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish. Dis Model Mech 4(6):801–813. https://doi.org/10.1242/dmm.007831
Nguyen AT, Emelyanov A, Koh CH, Spitsbergen JM, Parinov S, Gong Z (2012) An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening. Dis Model Mech 5(1):63–72. https://doi.org/10.1242/dmm.008367
Nicoli S, Presta M (2007) The zebrafish/tumor xenograft angiogenesis assay. Nat Protoc 2(11):2918–2923. https://doi.org/10.1038/nprot.2007.412
Parada-Kusz M, Penaranda C, Hagedorn EJ, Clatworthy A, Nair AV, Henninger JE, Ernst C, Li B, Riquelme R, Jijon H, Villablanca EJ, Zon LI, Hung D, Allende ML (2018) Generation of mouse-zebrafish hematopoietic tissue chimeric embryos for hematopoiesis and host-pathogen interaction studies. Dis Model Mech 11(11):dmm034876. https://doi.org/10.1242/dmm.034876
Park SW, Davison JM, Rhee J, Hruban RH, Maitra A, Leach SD (2008) Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. Gastroenterology 134(7):2080–2090. https://doi.org/10.1053/j.gastro.2008.02.084
Pettitt D, Arshad Z, Smith J, Stanic T, Hollander G, Brindley D (2018) CAR-T cells: a systematic review and mixed methods analysis of the clinical trial landscape. Mol Ther 26(2):342–353. https://doi.org/10.1016/j.ymthe.2017.10.019
Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F (2014) CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159(2):440–455. https://doi.org/10.1016/j.cell.2014.09.014
Rai K, Sarkar S, Broadbent TJ, Voas M, Grossmann KF, Nadauld LD, Dehghanizadeh S, Hagos FT, Li Y, Toth RK, Chidester S, Bahr TM, Johnson WE, Sklow B, Burt R, Cairns BR, Jones DA (2010) DNA demethylase activity maintains intestinal cells in an undifferentiated state following loss of APC. Cell 142(6):930–942. https://doi.org/10.1016/j.cell.2010.08.030
Romero R, Sayin VI, Davidson SM, Bauer MR, Singh SX, LeBoeuf SE, Karakousi TR, Ellis DC, Bhutkar A, Sanchez-Rivera FJ, Subbaraj L, Martinez B, Bronson RT, Prigge JR, Schmidt EE, Thomas CJ, Goparaju C, Davies A, Dolgalev I, Heguy A, Allaj V, Poirier JT, Moreira AL, Rudin CM, Pass HI, Vander HM, Jacks T, Papagiannakopoulos T (2017) Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis. Nat Med 23(11):1362–1368. https://doi.org/10.1038/nm.4407
Rycaj K, Tang DG (2015) Cell-of-origin of cancer versus cancer stem cells: assays and interpretations. Cancer Res 75(19):4003–4011. https://doi.org/10.1158/0008-5472.CAN-15-0798
Sanchez-Rivera FJ, Papagiannakopoulos T, Romero R, Tammela T, Bauer MR, Bhutkar A, Joshi NS, Subbaraj L, Bronson RT, Xue W, Jacks T (2014) Rapid modelling of cooperating genetic events in cancer through somatic genome editing. Nature 516(7531):428–431. https://doi.org/10.1038/nature13906
Shive HR, West RR, Embree LJ, Azuma M, Sood R, Liu P, Hickstein DD (2010) brca2 in zebrafish ovarian development, spermatogenesis, and tumorigenesis. Proc Natl Acad Sci U S A 107(45):19350–19355. https://doi.org/10.1073/pnas.1011630107
Shive HR, West RR, Embree LJ, Golden CD, Hickstein DD (2014) BRCA2 and TP53 collaborate in tumorigenesis in zebrafish. PLoS One 9(1):e87177. https://doi.org/10.1371/journal.pone.0087177
Smith MP, Ferguson J, Arozarena I, Hayward R, Marais R, Chapman A, Hurlstone A, Wellbrock C (2013) Effect of SMURF2 targeting on susceptibility to MEK inhibitors in melanoma. J Natl Cancer Inst 105(1):33–46. https://doi.org/10.1093/jnci/djs471
Solin SL, Shive HR, Woolard KD, Essner JJ, McGrail M (2015) Rapid tumor induction in zebrafish by TALEN-mediated somatic inactivation of the retinoblastoma1 tumor suppressor rb1. Sci Rep 5:13745. https://doi.org/10.1038/srep13745
Sonoshita M, Cagan RL (2017) Modeling human cancers in drosophila. Curr Top Dev Biol 121:287–309. https://doi.org/10.1016/bs.ctdb.2016.07.008
Tan DS, Haaland B, Gan JM, Tham SC, Sinha I, Tan EH, Lim KH, Takano A, Krisna SS, Thu MM, Liew HP, Ullrich A, Lim WT, Chua BT (2014) Bosutinib inhibits migration and invasion via ACK1 in KRAS mutant non-small cell lung cancer. Mol Cancer 13:13. https://doi.org/10.1186/1476-4598-13-13
Tang Q, Abdelfattah NS, Blackburn JS, Moore JC, Martinez SA, Moore FE, Lobbardi R, Tenente IM, Ignatius MS, Berman JN, Liwski RS, Houvras Y, Langenau DM (2014) Optimized cell transplantation using adult rag2 mutant zebrafish. Nat Methods 11(8):821–824. https://doi.org/10.1038/nmeth.3031
Tang Q, Moore JC, Ignatius MS, Tenente IM, Hayes MN, Garcia EG, Torres YN, Bourque C, He S, Blackburn JS, Look AT, Houvras Y, Langenau DM (2016) Imaging tumour cell heterogeneity following cell transplantation into optically clear immune-deficient zebrafish. Nat Commun 7:10358. https://doi.org/10.1038/ncomms10358
Tubbs A, Nussenzweig A (2017) Endogenous DNA damage as a source of genomic instability in Cancer. Cell 168(4):644–656. https://doi.org/10.1016/j.cell.2017.01.002
van der Ent W, Jochemsen AG, Teunisse AF, Krens SF, Szuhai K, Spaink HP, Hogendoorn PC, Snaar-Jagalska BE (2014) Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53. J Pathol 233(4):415–424. https://doi.org/10.1002/path.4378
van der Ent W, Burrello C, de Lange MJ, van der Velden PA, Jochemsen AG, Jager MJ, Snaar-Jagalska BE (2015) Embryonic zebrafish: different phenotypes after injection of human uveal melanoma cells. Ocul Oncol Pathol 1(3):170–181. https://doi.org/10.1159/000370159
Van Slyke CE, Bradford YM, Howe DG, Fashena DS, Ramachandran S, Ruzicka L (2018) Using ZFIN: data types, organization, and retrieval. Methods Mol Biol 1757:307–347. https://doi.org/10.1007/978-1-4939-7737-6_11
Veinotte CJ, Dellaire G, Berman JN (2014) Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era. Dis Model Mech 7(7):745–754. https://doi.org/10.1242/dmm.015784
Visvader JE (2011) Cells of origin in cancer. Nature 469(7330):314–322. https://doi.org/10.1038/nature09781
Wagner DS, Delk NA, Lukianova-Hleb EY, Hafner JH, Farach-Carson MC, Lapotko DO (2010) The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts. Biomaterials 31(29):7567–7574. https://doi.org/10.1016/j.biomaterials.2010.06.031
Wang X, Kopinke D, Lin J, McPherson AD, Duncan RN, Otsuna H, Moro E, Hoshijima K, Grunwald DJ, Argenton F, Chien CB, Murtaugh LC, Dorsky RI (2012) Wnt signaling regulates postembryonic hypothalamic progenitor differentiation. Dev Cell 23(3):624–636. https://doi.org/10.1016/j.devcel.2012.07.012
Wang J, Leng X, Wang G, Wan X, Cao H (2017) The construction of intrahepatic cholangiocarcinoma model in zebrafish. Sci Rep 7(1):13419. https://doi.org/10.1038/s41598-017-13815-0
Wang J, Fei F, Berberoglu MA, Sun S, Wang L, Dong Z, Wang X (2018) Csy4-based vector system enables conditional chimeric gene editing in zebrafish without interrupting embryogenesis. J Mol Cell Biol 10(6):586–588. https://doi.org/10.1093/jmcb/mjy017
Wang L, Chen H, Fei F, He X, Sun S, Lv K, Yu B, Long J, Wang X (2019) Patient-derived heterogeneous xenograft model of pancreatic cancer using zebrafish larvae as hosts for comparative drug assessment. J Vis Exp 146. https://doi.org/10.3791/59507
Waster P, Orfanidis K, Eriksson I, Rosdahl I, Seifert O, Ollinger K (2017) UV radiation promotes melanoma dissemination mediated by the sequential reaction axis of cathepsins-TGF-beta1-FAP-alpha. Br J Cancer 117(4):535–544. https://doi.org/10.1038/bjc.2017.182
White R, Rose K, Zon L (2013) Zebrafish cancer: the state of the art and the path forward. Nat Rev Cancer 13(9):624–636. https://doi.org/10.1038/nrc3589
Wu JQ, Zhai J, Li CY, Tan AM, Wei P, Shen LZ, He MF (2017) Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer. J Exp Clin Cancer Res 36(1):160. https://doi.org/10.1186/s13046-017-0631-0
Wu Q, Zheng K, Huang X, Li L, Mei W (2018) Tanshinone-IIA-based analogues of imidazole alkaloid act as potent inhibitors to block breast cancer invasion and metastasis in vivo. J Med Chem 61:10488–10501. https://doi.org/10.1021/acs.jmedchem.8b01018
Xu W, Foster BA, Richards M, Bondioli KR, Shah G, Green CC (2018) Characterization of prostate cancer cell progression in zebrafish xenograft model. Int J Oncol 52(1):252–260. https://doi.org/10.3892/ijo.2017.4189
Yan C, Yang Q, Shen HM, Spitsbergen JM, Gong Z (2017a) Chronically high level of tgfb1a induction causes both hepatocellular carcinoma and cholangiocarcinoma via a dominant Erk pathway in zebrafish. Oncotarget 8(44):77096–77109. https://doi.org/10.18632/oncotarget.20357
Yan C, Yang Q, Gong Z (2017b) Tumor-associated neutrophils and macrophages promote gender disparity in hepatocellular carcinoma in zebrafish. Cancer Res 77(6):1395–1407. https://doi.org/10.1158/0008-5472.CAN-16-2200
Yang HW, Kutok JL, Lee NH, Piao HY, Fletcher CD, Kanki JP, Look AT (2004) Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish. Cancer Res 64(20):7256–7262. https://doi.org/10.1158/0008-5472.CAN-04-0931
Yang XJ, Cui W, Gu A, Xu C, Yu SC, Li TT, Cui YH, Zhang X, Bian XW (2013) A novel zebrafish xenotransplantation model for study of glioma stem cell invasion. PLoS One 8(4):e61801. https://doi.org/10.1371/journal.pone.0061801
Yang J, Pei H, Luo H, Fu A, Yang H, Hu J, Zhao C, Chai L, Chen X, Shao X, Wang C, Wu W, Wan L, Ye H, Qiu Q, Peng A, Wei Y, Yang L, Chen L (2017) Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways. Oncotarget 8(1):915–932. https://doi.org/10.18632/oncotarget.13687
Yang Q, Yan C, Wang X, Gong Z (2019) Leptin induces muscle wasting in a zebrafish kras-driven hepatocellular carcinoma (HCC) model. Dis Model Mech 12(2):dmm038240. https://doi.org/10.1242/dmm.038240
Yao Y, Sun S, Fei F, Wang J, Wang Y, Zhang R, Wu J, Liu L, Liu X, Cui Z, Li Q, Yu M, Dang Y, Wang X (2017) Screening in larval zebrafish reveals tissue-specific distribution of fifteen fluorescent compounds. Dis Model Mech 10(9):1155–1164. https://doi.org/10.1242/dmm.028811
Yao Y, Sun S, Wang J, Fei F, Dong Z, Ke AW, He R, Wang L, Zhang L, Ji MB, Li Q, Yu M, Shi GM, Fan J, Gong Z, Wang X (2018) Canonical Wnt signaling remodels lipid metabolism in zebrafish hepatocytes following Ras oncogenic insult. Cancer Res 78(19):5548–5560. https://doi.org/10.1158/0008-5472.CAN-17-3964
Yee NS, Ignatenko N, Finnberg N, Lee N, Stairs D (2015) Animal models of cancer biology. Cancer Growth Metastasis 8(Suppl 1):115–118. https://doi.org/10.4137/CGM.S37907
Zhan T, Rindtorff N, Boutros M (2017) Wnt signaling in cancer. Oncogene 36(11):1461–1473. https://doi.org/10.1038/onc.2016.304
Zuckermann M, Hovestadt V, Knobbe-Thomsen CB, Zapatka M, Northcott PA, Schramm K, Belic J, Jones DT, Tschida B, Moriarity B, Largaespada D, Roussel MF, Korshunov A, Reifenberger G, Pfister SM, Lichter P, Kawauchi D, Gronych J (2015) Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling. Nat Commun 6:7391. https://doi.org/10.1038/ncomms8391
Financial Support
-
National Natural Science Foundation of China 81402582 and 81802333.
-
Natural Science Foundation of Shanghai 14YF1400600 and 18ZR1404500.
-
Natural Science Foundation of Guangdong Province 2018A030310053.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Yao, Y., Wang, L., Wang, X. (2020). Modeling of Solid-Tumor Microenvironment in Zebrafish (Danio Rerio) Larvae. In: Serpa, J. (eds) Tumor Microenvironment . Advances in Experimental Medicine and Biology, vol 1219. Springer, Cham. https://doi.org/10.1007/978-3-030-34025-4_22
Download citation
DOI: https://doi.org/10.1007/978-3-030-34025-4_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-34024-7
Online ISBN: 978-3-030-34025-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)